Oncology

Early-onset breast cancer incidence in the U.S. is rising, but new research suggests the increase is not uniform across all states. A recent study analyzing trends from 2001 to 2020 found that breast cancer rates in women under 40 have increased significantly in 21 states, with distinct regional differences.

A long-term study of assisted reproductive technology (ART) has found no increased risk of endometrial cancer, addressing concerns about the potential long-term effects of fertility treatments.

A new treatment combination has emerged for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who are ineligible for autologous stem cell transplant (ASCT).

18F-FDG PET and PET/CT scans show strong diagnostic accuracy in detecting histological transformations (HT) in indolent lymphomas, including Richter’s transformation (RT) in chronic lymphocytic leukemia (CLL), according to a new meta-analysis.

A machine learning model, SCORPIO, has shown promise in predicting the success of immune checkpoint inhibitors (ICIs) for patients with cancer.

A recent prospective cohort study highlights the incidence and clinical course of abemaciclib-induced interstitial lung disease (ILD) in patients with hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (MBC) previously treated with chemotherapy.

A new study has found that diet may play a key role in survival for women diagnosed with early-stage ovarian cancer.

The power of explainable artificial intelligence (xAI) combined with multimodal real-world data (RWD) to improve cancer prognosis across multiple cancer types was explored in a new study.